Verition Fund Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.86M | Sell |
5,703
-5,076
| -47% | -$1.66M | 0.01% | 1495 |
|
|
2025
Q1 | $2.91M | Buy |
10,779
+7,876
| +271% | +$2.13M | 0.01% | 1023 |
|
|
2024
Q4 | $683K | Sell |
2,903
-14,565
| -83% | -$3.43M | ﹤0.01% | 1715 |
|
|
2024
Q3 | $4.8M | Buy |
17,468
+10,053
| +136% | +$2.76M | 0.02% | 654 |
|
|
2024
Q2 | $1.8M | Buy |
7,415
+3,019
| +69% | +$734K | 0.01% | 919 |
|
|
2024
Q1 | $657K | Buy |
+4,396
| New | +$657K | ﹤0.01% | 1343 |
|
|
2023
Q4 | – | Sell |
-1,391
| Closed | -$246K | – | 1856 |
|
|
2023
Q3 | $246K | Buy |
+1,391
| New | +$246K | ﹤0.01% | 1522 |
|
|
2022
Q4 | – | Sell |
-4,827
| Closed | -$966K | – | 1675 |
|
|
2022
Q3 | $966K | Buy |
+4,827
| New | +$966K | 0.01% | 1167 |
|
|
2022
Q2 | – | Sell |
-2,404
| Closed | -$393K | – | 2187 |
|
|
2022
Q1 | $393K | Sell |
2,404
-4,982
| -67% | -$814K | ﹤0.01% | 1348 |
|
|
2021
Q4 | $1.25M | Buy |
7,386
+6,318
| +592% | +$1.07M | 0.01% | 787 |
|
|
2021
Q3 | $202K | Buy |
+1,068
| New | +$202K | ﹤0.01% | 1358 |
|
|
2020
Q3 | – | Sell |
-1,743
| Closed | -$258K | – | 954 |
|
|
2020
Q2 | $258K | Buy |
+1,743
| New | +$258K | 0.01% | 788 |
|
|
2020
Q1 | – | Sell |
-5,304
| Closed | -$611K | – | 505 |
|
|
2019
Q4 | $611K | Buy |
+5,304
| New | +$611K | 0.01% | 502 |
|
|
2019
Q3 | – | Sell |
-12,222
| Closed | -$887K | – | 900 |
|
|
2019
Q2 | $887K | Buy |
+12,222
| New | +$887K | 0.02% | 403 |
|
|
2018
Q3 | – | Sell |
-4,436
| Closed | -$437K | – | 1148 |
|
|
2018
Q2 | $437K | Sell |
4,436
-1,017
| -19% | -$100K | 0.03% | 671 |
|
|
2018
Q1 | $649K | Buy |
+5,453
| New | +$649K | 0.05% | 494 |
|
|
2017
Q3 | – | Sell |
-13,296
| Closed | -$1.06M | – | 1077 |
|
|
2017
Q2 | $1.06M | Buy |
+13,296
| New | +$1.06M | 0.1% | 156 |
|
|
2015
Q2 | – | Sell |
-5,495
| Closed | -$574K | – | 580 |
|
|
2015
Q1 | $574K | Buy |
5,495
+2,691
| +96% | +$281K | 0.07% | 73 |
|
|
2014
Q4 | $272K | Sell |
2,804
-918
| -25% | -$89.1K | 0.06% | 144 |
|
|
2014
Q3 | $291K | Buy |
+3,722
| New | +$291K | 0.04% | 385 |
|